The Current Ratio as of December 2024 (TTM) for Aquestive Therapeutics, Inc. (AQST) is 6.37

According to Aquestive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.37. This represents a change of 13.94% compared to the average of 5.59 of the last 4 quarters.

Aquestive Therapeutics, Inc. (AQST) Historical Current Ratio (quarterly & annually)

How has AQST Current Ratio performed in the past?

The mean historical Current Ratio of Aquestive Therapeutics, Inc. over the last ten years is 2.18. The current 6.37 Current Ratio has changed 29.14% with respect to the historical average. Over the past ten years (40 quarters), AQST's Current Ratio was at its highest in in the June 2024 quarter at 7.49. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Aquestive Therapeutics, Inc. (AQST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aquestive Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aquestive Therapeutics, Inc. (AQST) Average Current Ratio

How has AQST Current Ratio performed in the past?

The current Current Ratio of Aquestive Therapeutics, Inc. (AQST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aquestive Therapeutics, Inc. (AQST) Current Ratio vs. Peers

How is AQST’s Current Ratio compared to its peers?

Aquestive Therapeutics, Inc.’s Current Ratio is greater than Evoke Pharma, Inc. (1.44), greater than Adamis Pharmaceuticals Corporation (0.58), less than Guardion Health Sciences, Inc. (16.67), greater than AcelRx Pharmaceuticals, Inc. (4.42), less than Dynavax Technologies Corporation (13.23), greater than Amphastar Pharmaceuticals, Inc. (3.43), greater than Lantheus Holdings, Inc. (1.65), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than Alkermes plc (3.45), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Mallinckrodt plc (2.74), greater than Agile Therapeutics, Inc. (0.55), greater than Lifecore Biomedical, Inc. (1.83), greater than Organogenesis Holdings Inc. (3.09), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79),

Build a custom stock screener for Aquestive Therapeutics, Inc. (AQST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aquestive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aquestive Therapeutics, Inc. (AQST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aquestive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.